Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Billed for 8 Lanzol...

Billed for 8 Lanzol Junior Tablets, Supplied 7: Karnataka HC Quashes Rs 1.12 Case Against MedPlus

Written By : Susmita Roy Published On 2026-11-21T17:45:33+05:30  |  Updated On 21 Nov 2026 5:45 PM IST
Karnataka HC grants relief to NEET aspirant
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email
New Delhi: The Karnataka High Court has quashed criminal proceedings against MedPlus and four individuals in a case alleging that a customer was billed for eight Lanzol Junior 15 mg tablets but received only seven, with an alleged excess collection of Rs 1.12.
The court held that the allegations did not establish the pricing violation required under Clause 26 of the Drugs (Price Control) Order, 2013, as the prosecution had not alleged a sale above the applicable listed or labelled price. Continuing the prosecution, it ruled, would amount to an abuse of the process of law.

Justice S. Vishwajith Shetty passed the order on November 13, 2026, allowing Criminal Petition Nos. 355 of 2023 and 447 of 2023. The petitions sought to quash proceedings in C.C. No. 7712/2019, pending before the III Additional Metropolitan Magistrate, Bengaluru, under Clause 26 of the Drugs (Price Control) Order, 2013, and Section 7(1)(a)(ii) of the Essential Commodities Act, 1955. The order bears neutral citation 2026:KHC:63320.

The dispute originated in a purchase allegedly made on August 23, 2016, when Lanzol Junior 15 mg tablets were supplied to Shrinath Joshi, a senior reporter with ETV Kannada News, Bengaluru. According to the allegations reproduced in the order, the bill recorded a collection of Rs 40.32 for eight tablets, but only seven tablets were supplied. The complaint also alleged that the accused had collected Rs 1.12 in excess.

Joshi lodged a complaint on August 26, 2016. Subsequently, the Assistant Drugs Controller-I, Bengaluru Circle-4, instituted a private complaint against the accused for the alleged statutory offences. The High Court’s order records the billing amount, tablet shortage and alleged excess collection but does not explain the calculation underlying the Rs 1.12 figure.

Also Read:No Relief for Pharma Firm: Karnataka HC Refuses to Quash Drug Quality Case Over Impcal Tablets

Five accused challenged the resulting criminal proceedings through two petitions filed under Section 482 of the Code of Criminal Procedure. Criminal Petition No. 355/2023 was filed by P. Srinivas, described as a director of MedPlus, a unit of Rite Med Pharma Retail Pvt. Ltd., and M. Surendranath, described as its director in charge. They were accused Nos. 3 and 4 in the criminal case.

The connected Criminal Petition No. 447/2023 was filed by MedPlus, Padmanabhanagar, Bengaluru, its authorised signatory Sudhakar Reddy, and Rangaswamy K, described as the person in charge. They were accused Nos. 1, 2 and 5, respectively.

The petitioners, represented by advocate Akki Manjunath Gowda K, sought quashing of the entire proceedings against them. The State of Karnataka, acting through the Assistant Drugs Controller-I, Bengaluru Circle-4, was represented by High Court Government Pleader Rahul Rai K.

Although the court recorded that it heard counsel for both sides, the brief order does not separately reproduce their detailed oral submissions. The petitioners’ recorded request was to terminate the prosecution, while the prosecution case rested on the alleged shortage in the tablets supplied and the claimed excess collection. The order does not record a separate defence explanation for the transaction or a detailed State response supporting the application of Clause 26.

The central question examined by the court was whether those allegations attracted the specific price-control provision invoked in the complaint. Clause 26 regulates the price at which formulations may be sold to consumers.

The court reproduced the provision as follows:

“26. Control of sale prices of formulations.- No person shall sell any formulation to any consumer at a price exceeding the price specified in the current price list or price indicated on the label of the container or pack thereof, whichever is less.”

Interpreting the clause, Justice Shetty explained that it would apply where a formulation was sold at a price exceeding the price specified in the current price list or indicated on its container or pack, whichever was lower. The court therefore examined whether the prosecution had alleged that particular form of overpricing.

It found that the complaint instead concerned the supply of seven tablets against a bill for eight, together with the alleged excess collection of Rs 1.12. The court noted that the prosecution had not alleged that the accused charged more than the applicable price contemplated by the provision.

In paragraph 6, the court observed:

“In the case on hand, the allegation against the accused is that they had supplied 7 tablets instead of 8 tablets and they had collected excess amount of Rs.1.12 from the complainant. It is not the case of the prosecution that the accused persons had collected excess amount than the price indicated on the label of the container or pack thereof, whichever is less.”

The ruling thus turned on the relationship between the allegations and the statutory offence invoked. The court did not treat the allegation of short supply as sufficient, by itself, to establish a prosecution under Clause 26.

Also Read:Pharma Firm Allegedly Cheated of Rs 8.2 Crore, CA Arrested

Holding that continuation of the case was unwarranted, the court stated:

“Under the circumstances, I am of the opinion that prosecution of the petitioners for the aforesaid offences would not only cause embarassment to them, but would also amount to abuse of process of law.”

The exact operative ruling in paragraph 7 reads:

“Petitions are allowed. The entire proceedings in C.C.No.7712/2019 pending before the Court of III Addl. Metropolitan Magistrate, Bengaluru, for the offences punishable under Clause 26 of the Drugs (Price Control) Order, 2013, and Section 7(1)(a)(ii) of the Essential Commodities Act, 1955, stands quashed.”

The decision terminates the specified criminal proceedings against all five petitioners. Its reasoning concerns the failure of the allegations to attract the price-control offence invoked; the order does not separately determine whether the alleged tablet shortage occurred.

To view the official order, click the link below:

https://medicaldialogues.in/pdf_upload/2026/11/21/msmedplusvsthestateofkarnatakaon13november2026-484531.pdf
medpluskarnataka high courtlanzol junioroverchargingdrug price controlmed pharma retail

Medical Survey

Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Print Article
    Show Full Article
    Next Story
    Recommended For You
    NO DATA FOUND

    Editorial

    Why Does Nasal Congestion Persist Despite Allergic Rhinitis Treatment? Understanding Treatment Gaps and Rebound Congestion

    Why Does Nasal Congestion Persist Despite Allergic Rhinitis Treatment? Understanding Treatment Gaps...

    Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

    Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

    Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev Joshi

    Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev...

    Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

    Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

    Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination - Dr. Makarand Damle

    Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination...

    View All

    Journal Club Today

    Sun Pharma Introduces Cognitgrey, a Nutritional Supplement for Childrens Cognitive Development

    Sun Pharma Introduces Cognitgrey, a Nutritional Supplement for Children's Cognitive Development

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok